Barclays raises Tandem Diabetes target price to $20 from $18
TNDM•Barclays raised its target price for Tandem Diabetes to $20 from $18.
Related News
Gildan Activewear Inc.: RBC cuts target price to $50 from $70
GIL•
Iovance Biotherapeutics: Barclays raises target price to $19 from $18
IOVA•
Nasdaq trade halt continues; reason unavailable at 03:58 a.m.
JSPR•
Barclays raises Onterris target price to $19 from $15
ONT•
Gartner Inc.: Barclays raises target price to $185 from $150
IT•